Grants.gov · synopsis:posted
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- Verified from source 24 days ago
- Updated 24 days ago
- Amendment detected
- Agency
- National Institutes of Health
- Office
- HHS-NIH11
- Type
- synopsis:posted
- Kind
- grant
- Posted
- May 28, 2026
- Place
- —
- Notice ID
- 359671
- Source
- Grants.gov
- First seen
- Aug 27, 2026, 2:54 AM UTC
Full scope
The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies to later research and development (R&D) needed to develop a commercial product.
Description
The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies to later research and development (R&D) needed to develop a commercial product.
Eligibility
Only United States small business concerns (SBCs), as defined by the Small Business Administration (SBA)(sbir.gov/apply) are eligible to submit applications for this opportunity.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Documents
- PA-27-100-Revised-Full-Announcement.html Grants.gov access required
Contacts
-
National Institutes of Health
Related links
Full record synced 24 days ago from Grants.gov